sharp price declines due to decreases in current or expected earnings and may lack dividend payments that can help cushion
its share price during declining markets.
HEALTH CARE COMPANIES RISK. Health care companies, such as companies providing medical and healthcare goods and services, companies engaged in manufacturing medical equipment, supplies and pharmaceuticals, as well as operating health care facilities
and the provision of managed health care, may be affected by government regulations and government health care programs, increases
or decreases in the cost of medical products and services and product liability claims, among other factors. Many health care
companies are heavily dependent on patent protection, and the expiration of a company’s patent may adversely affect that company’s profitability. Health care companies are also subject to competitive forces that may result in price discounting, may be thinly capitalized
and susceptible to product obsolescence.
INDEX CONCENTRATION RISK. The Fund will be concentrated in an industry or a group of industries to the extent that the Index is so concentrated. To the extent that the Fund invests a significant percentage of its assets ina single asset class or the
securities of issuers within the same country, state, region, industry or sector, an adverse economic, business or political development
may affect the value of the Fund’s investments more than if the Fund were more broadly diversified. A significant exposure makes the Fund more susceptible to any single occurrence and may subject the Fund to greater market risk than a fund that is more broadly diversified.
INDEX PROVIDER RISK. There is no assurance that the Index Provider, or any agents that act on its behalf, will compile the Index accurately, or that the Index will be determined, maintained, constructed, reconstituted, rebalanced, composed, calculated
or disseminated accurately. The Index Provider and its agents do not provide any representation or warranty in relation to the
quality, accuracy or completeness of data in the Index, and do not guarantee that the Index will be calculated in accordance with its
stated methodology. The Advisor’s mandate as described in this prospectus is to manage the Fund consistently with the Index provided by the Index Provider. The Advisor relies upon the Index provider and its agents to accurately compile, maintain, construct,
reconstitute, rebalance, compose, calculate and disseminate the Index accurately. Therefore, losses or costs associated with any Index Provider
or agent errors generally will be borne by the Fund and its shareholders. To correct any such error, the Index Provider or its
agents may carry out an unscheduled rebalance of the Index or other modification of Index constituents or weightings. When the Fund in
turn rebalances its portfolio, any transaction costs and market exposure arising from such portfolio rebalancing will be borne
by the Fund and its shareholders. Unscheduled rebalances also expose the Fund to additional tracking error risk. Errors in respect of
the quality, accuracy and completeness of the data used to compile the Index may occur from time to time and may not be identified and
corrected by the Index Provider for a period of time or at all, particularly where the Index is less commonly used as a benchmark by
funds or advisors. For example, during a period where the Index contains incorrect constituents, the Fund tracking the Index would
have market exposure to such constituents and would be underexposed to the Index’s other constituents. Such errors may negatively impact the Fund and its shareholders. The Index Provider and its agents rely on various sources of information to assess the criteria
of issuers included in the Index, including information that may be based on assumptions and estimates. Neither the Fund nor the Advisor
can offer assurances that the Index’s calculation methodology or sources of information will provide an accurate assessment of included issuers. Unusual market conditions may cause the Index Provider to postpone a scheduled rebalance, which could cause the Index
to vary from its normal or expected composition. The postponement of a scheduled rebalance in a time of market volatility could
mean that constituents that would otherwise be removed at rebalance due to changes in market capitalizations, issuer credit ratings,
or other reasons may remain, causing the performance and constituents of the Index to vary from those expected under normal conditions.
Apart from scheduled rebalances, the Index Provider or its agents may carry out additional ad hoc rebalances to the Index
due to unusual market conditions or in order, for example, to correct an error in the selection of index constituents.
INFLATION RISK. Inflation risk is the risk that the value of assets or income from investments will be less in the future as inflation decreases the value of money. The current environment of elevated inflation may cause the present value of the Fund’s assets and distributions to decline.
INFORMATION TECHNOLOGY COMPANIES RISK. Information technology companies produce and provide hardware, software and information technology systems and services. These companies may be adversely affected by rapidly changing technologies, short
product life cycles, fierce competition, aggressive pricing and reduced profit margins, the loss of patent, copyright and
trademark protections, cyclical market patterns, evolving industry standards and frequent new product introductions. In addition, information
technology companies are particularly vulnerable to federal, state and local government regulation, and competition and consolidation,
both domestically and internationally, including competition from foreign competitors with lower production costs. Information
technology companies also heavily rely on intellectual property rights and may be adversely affected by the loss or impairment
of those rights.
LARGE CAPITALIZATION COMPANIES RISK. Large capitalization companies may grow at a slower rate and be less able to adapt to changing market conditions than smaller capitalization companies. Thus, the return on investment in securities of large capitalization
companies may be less than the return on investment in securities of small and/or mid capitalization companies. The performance
of large capitalization companies also tends to trail the overall market during different market cycles.
MARKET RISK. Market risk is the risk that a particular security, or shares of the Fund in general, may fall in value. Securities are subject
to market fluctuations caused by such factors as economic, political, regulatory or market developments, changes in interest
rates and perceived trends in securities prices. Shares of the Fund could decline in value or underperform other investments. In
addition,